|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Neumedicines Inc.
| | | Phone: | (626) 844-3800 | Fax: | (626) 844-3810 | Year Established: | 2003 | Main Contact: | Lena A. Basile, Ph.D., J.D., Founder, Chairman & CEO | | Other Contacts: | Scott Buckel, Ph.D., Senior Director of Analytical Development Rose Lopez, Senior Director of Quality & GMP Operations Zoya Gluzman-Poltorak, Ph.D., M.B.A., Senior Director of Development Christopher Lawrence, Ph.D., Senior Director of Research Vladimir Vainstein, MD, MSc, Acting CMO
| | Company Description | Neumedicines is a privately held, clinical stage, biotechnology company developing protein therapeutics that address unmet clinical and societal needs in Oncology, Infectious Disease, Hematology and Immunology. NM-IL-12 (aka HemaMax™, recombinant human interleukin-12 or rHuIL-12), the company’s lead product in development, targets multiple pathways of innate and adaptive immunity, as well as hematopoiesis, is being developed to address a broad range of clinical indications. | |
|
|
|
|
|